Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Trends in Diabetes-Related Mortality in the US

Lancet; ePub 2018 May 18; Gregg, Cheng, et al

Declining rates of vascular disease mortality in the US have led to a diversification of forms of diabetes-related mortality with important implications for clinical management, prevention, and disease monitoring. Using data from the National Health Interview Survey Linked Mortality files from 1985 to 2015, researchers estimated age-specific death rates and proportional mortality from all causes, vascular causes, cancers, and non-vascular, non-cancer causes among US adults by diabetes status. They found:

  • From 1988-1994, to 2010-2015, all-cause death rates declined by 20% every 10 years among US adults with diabetes.
  • Death from vascular causes decreased 32% every 10 years, deaths from cancers decreased 16% every 10 years, and the rate of non-vascular, non-cancer deaths declined by 8% every 10 years.
  • Death rates also declined significantly among people without diagnosed diabetes in all 4 major mortality categories.
  • However, the declines in death rates were significantly greater among those with diabetes for all-causes, vascular causes, and non-vascular, non-cancer causes.
  • Among those with diabetes, all-cause mortality rates declined most in men and adults aged 65-74 years.

Citation:

Gregg EW, Cheng YJ, Srinivasan M, et al. Trends in cause-specific mortality among adults with and without diabetes in the USA: An epidemiologic analysis of linked national survey and vital statistics data. [Published online ahead of print May 18, 2018]. Lancet. doi:10.1016/S0140-6736(18)30314-3.

This Week's Must Reads

TNF inhibitor prices rose despite increased drug class competition, San-Juan-Rodriguez A et al. JAMA Intern Med. 2019 Feb 18. doi: 10.1001/jamainternmed.2018.7656

List of medications linked to drug-induced lupus expands, Arnaud L et al. Ann Rheum Dis. 2019 Feb 4. doi: 10.1136/annrheumdis-2018-214598

HCV-infected patients in the ED should be tested for advanced liver fibrosis, Yu-Hsiang Hsieh Y-H. Am J Emerg Med. 2019;37[2]:286-90

Must Reads in Diabetes

Diabetic kidney disease, retinopathy associated with PAD in patients with foot ulcers, Megallaa MH et al. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1287-92.

Hospitalization Rates in Young-Onset Diabetes, Ann Intern Med; ePub 2019 Jan 15; Ke, Lau, et al

Long-Term Absolute Risk for CVD by FG Level, Diabetes Care; ePub 2019 Jan 7; Bancks, et al

Prediabetes Status & Lifestyle Modification , J Am Board Fam Med; 2019 Jan 4; Owei, et al

Second-Line ADMs & CV Events in T2D, JAMA Netw Open; ePub 2018 Dec 21; O’Brien, et al